Newswise COVID Experts

Filters close
Released: 19-Mar-2024 3:05 PM EDT
Targeting multiple COVID variants through the twist in the spike protein
University of Michigan

Teardrop-shaped particles designed to inactivate multiple strains of the SARS-CoV-2 virus could one day complement existing treatments for COVID-19, according to a new study led by researchers at the University of Michigan and Jiangnan University in Wuxi, China.

Released: 19-Mar-2024 1:40 PM EDT
New Study Reveals Insights into Lack of Durability in COVID Antibody Response to Infections and Vaccines
University of Maryland School of Medicine

Researchers at the Institute of Human Virology (IHV) at the University of Maryland School of Medicine published a new study in the Journal of Infectious Diseases investigating the short-lived antibody response following SARS-CoV-2, the virus that causes COVID.

Newswise: Choosing Over the Counter Drugs for COVID 19? It’s Complicated
Released: 19-Mar-2024 8:30 AM EDT
Choosing Over the Counter Drugs for COVID 19? It’s Complicated
Florida Atlantic University

Researchers take a closer look at both the potential benefits and risks of acetaminophen, NSAIDs such as ibuprofen, as well as aspirin for the selection of OTC drugs to treat mild symptoms of COVID-19.

Released: 18-Mar-2024 3:05 PM EDT
Text nudges can increase uptake of COVID-19 boosters– if they play up a sense of ownership of the vaccine
University of California, Los Angeles (UCLA), Health Sciences

Text nudges encouraging people to get the COVID-19 vaccine, which had proven effective in prior real-world field tests, are also effective at prompting people to get a booster. The key in both cases is to include in the text a sense of ownership in the dose awaiting them.

Newswise: Mutations do not predict the severity of current variants of SARS-CoV-2
Released: 15-Mar-2024 12:05 PM EDT
Mutations do not predict the severity of current variants of SARS-CoV-2
University of North Carolina at Charlotte

New research from UNC Charlotte’s Center for Computational Intelligence to Predict Health and Environmental Risks has found that the two most prevalent strains of the virus that cause COVID-19, SARS-CoV-2 variants BA.2.86 and JN.1, are not significantly better than their predecessor Omicron at evading immune responses and causing infections despite having a high number of mutations compared to previous variants.

1-Mar-2024 3:05 PM EST
New Study Reveals Covid-19 May Have Originated in a Lab
Society for Risk Analysis (SRA)

Research from the journal Risk Analysis, examined the likelihood of COVID-19 coming from an unnatural origin (i.e. from a laboratory.)

Not for public release

Embargo will expire: 14-Mar-2024 11:05 AM EDT Released to reporters: 14-Mar-2024 11:05 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 14-Mar-2024 11:05 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 14-Mar-2024 10:05 AM EDT
New bioengineered protein design shows promise in fighting COVID-19
NYU Tandon School of Engineering

In the wake of the COVID-19 pandemic, scientists have been racing to develop effective treatments and preventatives against the virus. A recent scientific breakthrough has emerged from the work of researchers aiming to combat SARS-CoV-2, the virus responsible for COVID-19.

   
Released: 14-Mar-2024 9:00 AM EDT
Breast Cancer Diagnoses Plummeted During First Year of Pandemic
American College of Surgeons (ACS)

There was a 15-20% decrease in newly diagnosed breast cancer cases reported to American College of Surgeons Commission on Cancer sites in 2020 compared to 2019.

Newswise: Long COVID patients report improvements following self-regulation therapy, study finds
Released: 13-Mar-2024 2:05 PM EDT
Long COVID patients report improvements following self-regulation therapy, study finds
University of California, Los Angeles (UCLA), Health Sciences

A new UCLA-led study suggests that some people living with long COVID may be able to alleviate certain symptoms by using short-term, self-regulating therapies.



close
2.50581